133 related articles for article (PubMed ID: 35339267)
1. Histologically Agressive Basal Cell Carcinoma With Particular Emphasis On Galeal Infiltration Of The Scalp.
Requena C; Serra-Guillén C; Sanmartín O
Actas Dermosifiliogr; 2022 Jun; 113(6):575-582. PubMed ID: 35339267
[TBL] [Abstract][Full Text] [Related]
2. Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes.
Camela E; Ilut Anca P; Lallas K; Papageorgiou C; Manoli SM; Gkentsidi T; Eftychidou P; Liopyris K; Sgouros D; Apalla Z; Lallas A
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837550
[No Abstract] [Full Text] [Related]
3. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
4. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
5. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
[TBL] [Abstract][Full Text] [Related]
6. Key characteristics of basal cell carcinoma with large subclinical extension.
Greywal T; Goldenberg A; Eimpunth S; Jiang SB
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):485-490. PubMed ID: 31419354
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma with intravascular invasion: A case report and review of the literature.
Mazloom S; Rich M; Grider D; Phillips M
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677816
[TBL] [Abstract][Full Text] [Related]
8. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
[TBL] [Abstract][Full Text] [Related]
9. Face and Scalp Basal Cell Carcinoma Treatment: A Review of the Literature.
Bernardini N; Skroza N; Zuber S; Tolino E; Balduzzi V; Mambrin A; Marchesiello A; Anzalone A; Colapietra D; Proietti I; Potenza C
Acta Dermatovenerol Croat; 2019 Mar; 27(1):22-27. PubMed ID: 31032787
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
[TBL] [Abstract][Full Text] [Related]
11. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma.
Brown CI; Perry AE
Am J Dermatopathol; 2000 Apr; 22(2):123-5. PubMed ID: 10770431
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment and dilemmas in the treatment of basal cell carcinomas with intracranial propagation.
Rasulić LG; Jovanović MD
Vojnosanit Pregl; 2014 Nov; 71(11):1045-8. PubMed ID: 25536808
[TBL] [Abstract][Full Text] [Related]
13. The correlation between tumor thickness and aggressive histopathological pattern in Basal cell carcinoma.
Gülseren D; Elçin G; Erkin G; Gököz Ö
J Cosmet Dermatol; 2022 Jun; 21(6):2577-2580. PubMed ID: 35726442
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma: clinical and pathological features.
Di Stefani A; Chimenti S
G Ital Dermatol Venereol; 2015 Aug; 150(4):385-91. PubMed ID: 26099353
[TBL] [Abstract][Full Text] [Related]
15. A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma.
Christian MM; Moy RL; Wagner RF; Yen-Moore A
Dermatol Surg; 2001 May; 27(5):441-5. PubMed ID: 11359490
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review.
Conte S; Ghezelbash S; Nallanathan B; Lefrançois P
Curr Oncol; 2023 Nov; 30(11):9906-9928. PubMed ID: 37999140
[TBL] [Abstract][Full Text] [Related]
17. Scalp Basal Cell Carcinoma: Review of 2,202 Cases.
Cho M; Lee J; James CL; Marshman G; Huilgol SC
Dermatol Surg; 2016 Jul; 42(7):834-41. PubMed ID: 27243131
[TBL] [Abstract][Full Text] [Related]
18. Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California.
Wrone DA; Swetter SM; Egbert BM; Smoller BR; Khavari PA
J Am Acad Dermatol; 1996 Dec; 35(6):907-10. PubMed ID: 8959949
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
Merritt BG; Snow SN; Longley BJ
Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
[TBL] [Abstract][Full Text] [Related]
20. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
